leisure time -WSS

leisure time

author：entertainment 2025-09-02 08:19:49 - browse：1

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： How to address the problem of discarded donor organs

knowledge

WSS

Eli Lilly’s Mounjaro succeeds in second weight

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Novo: Oral version of Ozempic leads to 15% weight loss

Biotech companies concerned about China biosecurity crackdown

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

focus

leisure time

focus

Cancer drug shortages should be causing more outrage

How to fix the rural physician shortage in the U.S.

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mom launches Girl Scout troop for LGBTQ youth in Texas

Tori Bowie and the unacceptable rates of Black maternal death

Mom launches Girl Scout troop for LGBTQ youth in Texas

Medicare details structure of new drug price negotiation program

The thinking behind the controversial eating disorder chatbot Tessa

Walensky prepares to leave CDC — and Congress — behind

AstraZeneca loses challenge to Medicare drug price negotiation

knowledge

How to address the problem of discarded donor organs

Why getting cancer drugs just got harder for rural patients

Novo pauses ads for weight loss drug Wegovy amid demand

Novo pauses ads for weight loss drug Wegovy amid demand

How to address the problem of discarded donor organs

A Q&A with Aletha Maybank, AMA’s chief health equity officer

focus

explore

knowledge

Wikipedia